Corrine Voils, PhD


  • Morgridge Distinguished Chair in Health Services Research
  • Director, WiSOR
  • Vice Chair for Diversity, Equity, and Inclusion
  • ICTR KL2 Director
  • Division of Minimally Invasive Surgery
(608) 262-9636

K6/100 Clinical Science Center
600 Highland Ave
Madison, WI 53792


  • PhD, University of Kentucky, Lexington, KY, 2001
  • MS, University of Kentucky, Lexington, KY, 1998
  • BA, University of Texas at El Paso, El Paso, TX, 1995

Research Interests

Dr. Voils, a social psychologist, uses qualitative and quantitative methodologies to study and improve treatment adherence. One area of interest is in developing and evaluating behavioral interventions to improve long-term weight loss. She led randomized controlled trials (RCT) to evaluate a telephone-delivered, spouse-assisted intervention to improve patient cholesterol levels (CouPLES) and to evaluate a weight loss maintenance intervention following behavioral weight loss (MAINTAIN). More recently she has been adapting this work to promote weight loss maintenance following weight loss surgery and to evaluate the impact of financial incentives for dietary self-monitoring and weight loss.

A second area of interest is genomics health services research. Dr. Voils led an RCT to evaluate the clinical utility of genetic testing for type 2 diabetes. She is currently PI of an RCT to evaluate effectiveness and implementation of an information technology innovation that collects patient-entered family history and provides decision support to patients and providers.

Dr. Voils also has a strong interest in developing novel research methodologies. She developed methods for synthesizing qualitative and quantitative research findings. She also developed a self-report measure of medication nonadherence that is currently being translated to other languages and disseminated in research and clinical settings in the United States and abroad. For more information about this measure, click here.

Dr. Voils’ Lab

Recent Publications

  • Prevalence of High-Grade Anal Dysplasia and Anal Cancer in Veterans Living With HIV and CD4/CD8 Ratio as a Marker For Increased Risk: A Regional Retrospective Cohort Study.
    Sanger CB, Xu Y, Carchman E, Lawson EH, Heise CP, Striker R, Voils CI
    Dis Colon Rectum 2021 Jul 01; 64(7): 805-811
    [PubMed ID: 34086000]

  • Two-year weight trajectories following completion of a behavioral weight loss maintenance intervention.
    Gavin KL, Voils CI, Yancy WS, Olsen MK
    Obes Sci Pract 2021 Jun; 7(3): 321-325
    [PubMed ID: 34123398]

  • Prenatal care experiences among pregnant women with obesity in Wisconsin, United States: a qualitative quality improvement assessment.
    Hurst DJ, Schmuhl NB, Voils CI, Antony KM
    BMC Pregnancy Childbirth 2021 Feb 15; 21(1): 139
    [PubMed ID: 33588775]

  • CD4/CD8 Ratio as a Novel Marker for Increased Risk of High-Grade Anal Dysplasia and Anal Cancer in HIV+ Patients: A Retrospective Cohort Study.
    Geltzeiler CB, Xu Y, Carchman E, Ghouse Y, Beczkiewicz J, Son J, Voils CI, Striker R
    Dis Colon Rectum 2020 12; 63(12): 1585-1592
    [PubMed ID: 33149020]

  • A randomized feasibility pilot trial of a financial incentives intervention for dietary self-monitoring and weight loss in adults with obesity.
    Voils CI, Pendergast J, Hale SL, Gierisch JM, Strawbridge EM, Levine E, McVay MA, Reed SD, Yancy WS, Shaw RJ
    Transl Behav Med 2021 04 26; 11(4): 954-969
    [PubMed ID: 33245118]

All Publications on PubMed